![]()
Viral Testing Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global viral testing market is anticipated to reach a value of $3.1 billion by 2025, driven by increasing prevalence of viral infections and growing demand for early detection and treatment. Factors such as technological advancements in diagnostic tests and rising awareness about infectious diseases are expected to boost market growth.
Request Sample Report
◍ Roche
◍ Agilent Technologies
◍ Thermo Fisher Scientific
◍ QIAGEN International
◍ Lonza
◍ Wuxi Pharmatech (Cayman)
◍ Merck
◍ Eurofins Scientific
◍ General Electric
◍ Danaher
◍ Bio-Rad Laboratories
◍ BD
◍ Biospherix
◍ Novogene Corporation
◍ Sartorius
The competitive landscape of the viral testing market includes key players such as Roche, Agilent Technologies, Thermo Fisher Scientific, QIAGEN International, Lonza, Merck, Eurofins Scientific, General Electric, Danaher, Bio-Rad Laboratories, BD, and others. These companies provide various viral testing products and services to help in the detection and management of viral infections, contributing to the growth of the viral testing market.
- Roche: $60.2 billion sales revenue
- Agilent Technologies: $5.34 billion sales revenue
- Thermo Fisher Scientific: $32.22 billion sales revenue
Request Sample Report
Laboratory
Hospital
Home Care
Academic Institute
◍ Direct Fluorescent Antibody (DFA) Test
◍ Immunochromatographic Assay
◍ RT-PCR-Based Test
◍ Agglutination Assay ◍ Flow-Through Assay
Solid-Phase Assay
Request Sample Report
Request Sample Report
$ 1.70 Billion